Abstract
Guanylate kinases (GMPK) from Mycobacterium tuberculosis, Mus musculus and Saccharomyces cereviae were submitted to virtual screening in order to determine protein-ligand interactions specific to M. tuberculosis. The opening of the cleft between CORE, LID and GMP domains was found to have a large influence on the established interactions and on the determination of ligands binding specifically to the M. tuberculosis GMPK. An extended definition of the active site pocket, allowing to be more discriminant between Mycobacterium tuberculosis and M. musculus, is given. A virtual screening run with the extended pocket definition, was used to select compounds having high docking scores on M. tuberculosis GMPK and low ones on M. musculus GMPK. The protein residues involved in hydrogen bonds with ligands were the same than in the GMPK-GMP complex, but the chemical functions of the ligand involved in these hydrogen bonds are often different. On the other hand, the hydrophobic interactions are different from the ones observed in the GMPK-GMP structure, and may be a way to increase the specificity between the M. tuberculosis and M. musculus GMPKs.
Keywords: Mycobacterium tuberculosis, GMPK, Guanylate monophosphate kinase, Virtual screening, ICM
Letters in Drug Design & Discovery
Title: Virtual Screening of the Guanylate Monophosphate Kinase (GMPK) Family: Investigating the Rules of Ligand Specificity
Volume: 5 Issue: 5
Author(s): Therese E. Malliavin, Helene Munier-Lehman and Veronique Stoven
Affiliation:
Keywords: Mycobacterium tuberculosis, GMPK, Guanylate monophosphate kinase, Virtual screening, ICM
Abstract: Guanylate kinases (GMPK) from Mycobacterium tuberculosis, Mus musculus and Saccharomyces cereviae were submitted to virtual screening in order to determine protein-ligand interactions specific to M. tuberculosis. The opening of the cleft between CORE, LID and GMP domains was found to have a large influence on the established interactions and on the determination of ligands binding specifically to the M. tuberculosis GMPK. An extended definition of the active site pocket, allowing to be more discriminant between Mycobacterium tuberculosis and M. musculus, is given. A virtual screening run with the extended pocket definition, was used to select compounds having high docking scores on M. tuberculosis GMPK and low ones on M. musculus GMPK. The protein residues involved in hydrogen bonds with ligands were the same than in the GMPK-GMP complex, but the chemical functions of the ligand involved in these hydrogen bonds are often different. On the other hand, the hydrophobic interactions are different from the ones observed in the GMPK-GMP structure, and may be a way to increase the specificity between the M. tuberculosis and M. musculus GMPKs.
Export Options
About this article
Cite this article as:
Malliavin E. Therese, Munier-Lehman Helene and Stoven Veronique, Virtual Screening of the Guanylate Monophosphate Kinase (GMPK) Family: Investigating the Rules of Ligand Specificity, Letters in Drug Design & Discovery 2008; 5 (5) . https://dx.doi.org/10.2174/157018008784912045
DOI https://dx.doi.org/10.2174/157018008784912045 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Isonicotinic Acid Hydrazide Derivatives: Synthesis, Antimycobacterial, Antiviral, Antimicrobial Activity and QSAR Studies
Letters in Drug Design & Discovery Liposome Technology for Drug Delivery Against Mycobacterial Infections
Current Pharmaceutical Design Control by Substrate of the Cytochrome P450-Dependent Redox Machinery: Mechanistic Insights
Current Drug Metabolism Mannose Binding Lectin: A Potential Biomarker for Many Human Diseases
Current Medicinal Chemistry Polypharmacology in a Single Drug: Multitarget Drugs
Current Medicinal Chemistry Chemical Constituents from the Chinese Bryophytes and Their Reversal of Fungal Resistance
Current Organic Chemistry Mouse Models of Autoimmune Diseases - Autoimmune Myocarditis
Current Pharmaceutical Design Editorial (Thematic Issue: The Thoracic Space: An Amazing Pandora’s Box!)
Current Respiratory Medicine Reviews Pyrrole: Chemical Synthesis, Microwave Assisted Synthesis, Reactions and Applications: A Review
Current Organic Chemistry Recent Advances and Future Perspectives of Triazole Analogs as Promising Antiviral Agents
Mini-Reviews in Medicinal Chemistry Rapid Nucleic Acid Reaction Circuits for Point-of-care Diagnosis of Diseases
Current Topics in Medicinal Chemistry Identifying Key Regulator Genes for Tuberculosis by Differential Co- Expression Analysis of Gene Expression Profiling
Current Bioinformatics Occurrence and Biological Properties of Sphingolipids - A Review
Current Nutrition & Food Science In-Situ Formation of Liposome of Rifampicin: Better Availability for Better Treatment
Current Drug Delivery Structural and Functional Properties of NAD Kinase, a Key Enzyme in NADP Biosynthesis
Mini-Reviews in Medicinal Chemistry Recent Patents on Self-Quenching DNA Probes
Recent Patents on DNA & Gene Sequences Screening for Novel Antituberculosis Agents that are Effective Against Multidrug Resistant Tuberculosis
Current Topics in Medicinal Chemistry Host-Directed Therapeutics against Mycobacterial Infections
Current Pharmaceutical Design Pathogen Interactions with DC-SIGN Modulate Immune Responses: A Toll Tale?
Current Immunology Reviews (Discontinued) Immunomodulatory Drugs as a Therapy for Multiple Myeloma
Current Pharmaceutical Biotechnology